Bioactive components and the effect of hydroalcoholic extract of Vaccinium myrtillus on postprandial atherosclerosis risk factors in rabbits

Pakistan Journal of Medical Sciences

Volumn 29, Issue 1 SUPPL., 2013, Pages 384-389

  Madihi, Yahya ^a   Merrikhi, Alireza ^a   Baradaran, Azar ^b   Ghobadi, Shamin ^c   Shahinfard, Najmeh ^c   Ansari, Roya ^c   Karimi, Ali ^c   Mesripour, Azadeh ^c   Rafieian Kopaei, Mahmoud ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Cholesterol; Coronary heart disease; Vaccinium myrtillus

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN B; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRITE; VACCINIUM MYRTILLUS EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIOCHEMICAL COMPOSITION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; HEART PROTECTION; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MALE; NONHUMAN; PHYTOCHEMISTRY; POSTPRANDIAL STATE; RABBIT; RISK ASSESSMENT;

EID: 84874714688     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.291(Suppl).3539     Document Type: Article

References (58)

1. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 1993;362:801-809.
2. Tayebi Khosroshahi H. Short history about renal transplantation program in Iran and the world: Special focus on world kidney day 2012. J Nephropathology. 2012;1(1):5-10.
3. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathology. 2012;1(3):162-163.
4. Caggiula AW, Mustad VA. Effects of dietary fat and fatty acids on coronary artery disease risk and total and lipoprotein cholesterol concentrations epidemiology studies. Am J Clin Nutr. 1997;65:1597S-1610S.
5. Stamler J, Wentworth D, Neaton J. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous or graded. J Am Med Assoc. 1986;256:2823-2828.
6. Slyper HA. Low-density lipoprotein density and atherosclerosis. JAMA. 1994;272(4):305-308.
7. Assadi F. The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathology. 2012;1(2):61-64.
8. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathology. 2012;1(2):101-108.
9. Sahni N, Gupta KL. Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients. J Nephropathology. 2012;1(3):134-142.
10. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathology. 2012;1(3):143-151.
11. Bianchi C, Miccoli R, Penno G and Del-Prato S. Primary prevention of cardiovascular disease in people with dysglycemia. Diabetes Care. 2008;31:208-214.
12. Stensvold I, Tverdal A, Urdal P. Graff-Iversen S. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. BMJ. 1993;307:1318-1322.
13. Baradaran A. Lipoprotein (a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathology. 2012;1(3):126-129.
14. Solati M, Mahboobi HR. Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients. J Nephropathology. 2012;1(3):123-125.
15. Tverdal A, Foss OP, Leren P, Holme I, Lund-Larsen PIG and Bjartveit K. Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol. 1989;129:458-465.
16. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276(11):882-888.
17. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309-316.
18. Kane JP, Chen GC, Hamilton RL, Hardman DA, Malloy MJ, Havel RJ. Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. ATVB. 1983;3:47-56.
19. Shanmugam KR, Ramakrishna CH, Mallikarjuna K, Reddy KS. The impact of ginger on kidney carbohydrate metabolic profiles in STZ-induced diabetic rats. Asian J Exp Sci. 2009;23:127-134.
20. Khajehdehi P. Turmeric: Reemerging of a neglected Asian traditional remedy. J Nephropathology. 2012; 1(1):17-22.
21. Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia: A systematic review. Curr Pharm Des. 2010;16:2935-2947.
22. Asgary S, Haghjooyjavanmard S, Setorki M, Rafieian-kopae M, Haghighi S, Eidi A, et al. The postprandial effect of apple juice intake on some of the biochemical risk factors of atherosclerosis in male rabbit. J Med Plants Res. 2009;3:785-790.
23. Rafieian-Kopaei M, Asgary S, Adelnia A, Setorki M, Khazaei M, Kazemi S, et al. The effects of cornelian cherry on atherosclerosis and atherogenic factors in hypercholesterolemic rabbits. J Med Plants Res. 2011;5:2670-2676.
24. Sukandar EY, Nurdewi, Elfahmi. Antihypercholesterolemic Effect of Combination of Guazuma ulmifolia lamk. leaves and Curcuma xanthorrhiza roxb. rhizomes extract in wistar rats. Int J Pharmacol. 2012;8:277-282.
25. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. Resveratrol, pterostilbene and piceatannol in Vaccinium berries. J Agric Food Chem. 2004;52:4713-4719.
26. Beattie J, Crozier A, Duthie GG. Potential health benefits of berries. Curr Nutr Food Sci. 2005;1:71-86.
27. Wang SY, Jiao H. Scavenging capacity of berrycrops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen. J Agric Food Chem. 2000;48(11):5677-5684.
28. Youdim KA, McDonald J, Kalt W, Joseph JA. Potential role of dietary flavonoids in reducing microvascular endothelium Vulnerability to oxidative and inflammatory insults. J Nutr Biochem. 2002;13:282-288.
29. Bell DR, Gochenaur K. Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts. J Applied Physiol. 2006;100:1164-1170.
30. Jovancevic M, Balijagic J, Menkovic N, Savikin K, Zadunic G, Jankovic T, et al. Analysis of phenolic compounds in wild populations of bilberry (Vaccinium myrtillus L.) from Montenegro. J Med Plants Res. 2011;5:910-914.
31. Francis FJ. Anthocyanins as Food Colors. Markakis, P. (Ed.). Academic Press, New York. 1982.
32. Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. J Med Food. 2011;14:969-9674.
33. Bahmani M, Rafieian-kopaei M, Parsaei P. Mohsenzadegan A. The anti-leech effect of Peganum harmala L. extract and some anti-parasite drugs on Limnatis nilotica. Afr J Microbiol Res. 2012;6:2586-2590.
34. Mirzaei MGh, Sewell RDE, Kheiri S, Rafieian-Kopaei M. A clinical trial of the effect of St. John's wort on migraine headaches in patients receiving sodium valproate. J Med Plants Res. 2012;6:1524-1531.
35. Ansar S, Koska J, Reaven PD. Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: Focus on incretins. Cardiovasc Diabetol. 2011;10:61-88.
36. Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathology. 2012;1(2):81-82.
37. Tavafi M. Inhibition of gentamicin - induced renal tubular cell necrosis. J Nephropathology. 2012;1(2):83-86.
38. Nematbakhsh M, Ashrafi F, Pezeshki Z, Fatahi Z, Kianpoor F, anei MH, et al. A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model. J Nephropathology. 2012;1(3):190-193.
39. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, Baradaran A, Gheissari A, Rouhi H. Erythropoietin ameliorates genetamycininduced renal toxicity: A biochemical and histopathological study. J Nephropathology. 2012;1(2):109-116.
40. Pompella A. Biochemistry and histochemistry of axidant stress and lipid peroxidation. Int Vitam Nutr Res. 1997;67:289-297. PMID: 9350469.
41. Kunchandy E, Rao MNA. Oxygen radical scavenging activity of curcumin. Int J Pharm. 1990;58:237-240.
42. Laplaud PM, Lekrbre A, Champan A. Antioxidant action of vaccinium myrthillus extract on human low density lipoproteins in vitro: Initial observations. Fund Clin Pharmacol. 1997;11:35-40.
43. Roghani M, Baluchnejadmojarad T, Taheri S. The effect of feeding with aerial part of vaccinium myrtillus on blood glucose and lipids of diabetic rats. Iranian J Diabetes Lipid Disorders. 2007;792:153-158.
44. Tomono S, Kawazu S, Kato N, Ono T, Ishii C. Uptake of remnant like particles (RLP) from diabetic patients from mouse peritoneal macrophage. J Atheroscler Tromb. 1994;1:98-102.
45. Tanaka A. Postprandial hyperlipidemia and atherosclerosis. J Atheroscler Thromb. 2004;11:322-329.
46. Cignarella A, Nastasi M, Cavalli E, Puglisi L. Novel lipid lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment in several models of dyslipidaemia: A comparison with ciprofibrate. Thromb Res. 1996;84:311-322.
47. Kazumi T, Odaka H, Hozumi T, Ishida Y, Amano N, Yoshino G. Effects of dietary fructose or glucose on triglyceride production and lipogenic enzyme activities in the liver of wistar fatty rats, an animal model of NIDDM. Endocr J. 1997;44:239-240.
48. Pourahmad J, Eskandari MR, Shakibaei R. Kamalinejad M. A search for hepatoprotective activity of aqueous extract of Rhus coriaria L. against oxidative stress cytotoxicity. Food Chem Toxicol. 2010;48:854-858.
49. Naderi GH, Asgary S, Gharipour M, Taher M, Khosravi E, Nikkhoo N. Antioxidant effect of Peper Nigrum on hepatocyte membrane and LDL oxidation and nonenzymatic glycosylation of hemoglobin. Hakim J. 2008;10(4):11-16.
50. Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol. 1995;25:674-678.
51. Okopien B, Krysiak R, Madej A, Belowski D, Zielinski M, Kowalski J. Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia. Pol J Pharmacol. 2004;56(6):781-787.
52. Song JC, White CM. Do HMG-CoA reductase inhibitors affect fibrinogen? Ann Pharmacother. 2001;35:236-241.
53. Noto D, Barbagallo CM, Cefalu AB, Cavera G, Sapienza M. Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: Results of an 11-year follow-up. Thromb. Haemost. 2002;87:206-210.
54. Tolouian R, Hernandez GT. Prediction of Diabetic Nephropathy: The need for a sweet biomarker. J Nephropathology. 2013;2(1):4-5.
55. Rouhi H, Ganji F. Effect of N-acetyl cysteine on serum Lipoprotein (a) and proteinuria in type 2 diabetic patients. J Nephropathology. 2013;2(1):61-66.
56. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathology. 2013;2(1):20-27.
57. Vafa MR, Haghighatjoo E, Shidfar F, Afshari S, Gohari MR, Ziaee A. Effects of apple consumption on lipid profile of hyperlipidemic and overweight men. Int J Prev Med. 2011;2(2):94-100.
58. Asgary S, Rahimi P, Mahzouni P, Madani H. Antidiabetic effect of hydroalcoholic extract of Carthamus tinctorius L. in alloxaninduced diabetic rats. J Res Med Sci. 2012;17(4):386-392.